Efficacy and Safety of rTMS for Cognitive Rehabilitation in Moyamoya Disease

NCT03543748 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-06-01

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and effectiveness of transcranial magnetic stimulation (TMS) therapy in moyamoya patients who received surgical revascularization.

Conditions

  • Moyamoya Disease

Interventions

DEVICE

Transcranial Magnetic Stimulation

A total of 2000 trains will be delivered successively. The pulses will be delivered at 80% of motor thresholds.

DEVICE

Sham Transcranial Magnetic Stimulation

The sham coil looks and sounds just like the real coil, but produces a negligible magnetic field.

Sponsors & Collaborators

  • Huashan Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2019-01-01
Completion
2019-03-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03543748 on ClinicalTrials.gov